Wealthspire Advisors (New York)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.63M | Buy |
|
|||||
|
2025
Q2 | $1.87M | Buy |
|
|||||
|
2025
Q1 | $1.8M | Buy |
|
|||||
|
2024
Q4 | $1.11M | Sell |
|
|||||
|
2024
Q3 | $1.89M | Buy |
|
|||||
|
2024
Q2 | $1.29M | Sell |
|
|||||
|
2024
Q1 | $1.17M | Buy |
|
|||||
|
2023
Q4 | $815K | Sell |
|
|||||
|
2023
Q3 | $772K | Buy |
|
|||||
|
2023
Q2 | $542K | Buy |
|
|||||
|
2023
Q1 | $500K | Sell |
|
|||||
|
2022
Q4 | $694K | Buy |
|
|||||
|
2022
Q3 | $348K | Buy |
|
|||||
|
2022
Q2 | $299K | Sell |
|
|||||
|
2022
Q1 | $303K | Sell |
|
|||||
|
2021
Q4 | $523K | Sell |
|
|||||
|
2021
Q3 | $477K | Buy |
|
|||||
|
2021
Q2 | $303K | Sell |
|
|||||
|
2021
Q1 | $360K | Buy |
|
|||||
|
2020
Q4 | $346K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.07M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $46K | Buy |
|